N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms ; volume:16 ; number:1 ; day:15 ; month:9 ; year:2016 ; pages:1-9 ; date:12.2016
BMC psychiatry ; 16, Heft 1 (15.9.2016), 1-9, 12.2016
- Urheber
-
Rossell, Susan L.
- Beteiligte Personen und Organisationen
-
Francis, Paul S.
Galletly, Cherrie
Harris, Anthony
Siskind, Dan
Berk, Michael
Bozaoglu, Kiymet
Dark, Frances
Dean, Olivia
Liu, Dennis
Meyer, Denny
Neill, Erica
Phillipou, Andrea
Sarris, Jerome
Castle, David J.
SpringerLink (Online service)
- DOI
-
10.1186/s12888-016-1030-3
- URN
-
urn:nbn:de:1111-201610163144
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rossell, Susan L.
- Francis, Paul S.
- Galletly, Cherrie
- Harris, Anthony
- Siskind, Dan
- Berk, Michael
- Bozaoglu, Kiymet
- Dark, Frances
- Dean, Olivia
- Liu, Dennis
- Meyer, Denny
- Neill, Erica
- Phillipou, Andrea
- Sarris, Jerome
- Castle, David J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo